<DOC>
	<DOC>NCT02707224</DOC>
	<brief_summary>A randomized, single-dose, open, crossover clinical trial to compare the pharmacokinetics of DP-R208 (Candesartan cilexetil and Rosuvastatin calcium fixed dose combinations) in comparison to each component administered alone in healthy male volunteers</brief_summary>
	<brief_title>Clinical Trial to Compare the Pharmacokinetics of DP-R208</brief_title>
	<detailed_description />
	<mesh_term>Candesartan</mesh_term>
	<mesh_term>Candesartan cilexetil</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>BMI 17.5~30.5 signed the informed consent form prior to the study participation Clinically significant disease Previously donate whole blood within 60 days or component blood within 14 days Clinically significant allergic disease Taken IP in other trial within 90 days An impossible one who participates in clinical trial by investigator's decision including laboratory test result</criteria>
	<gender>Male</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>DP-R208</keyword>
</DOC>